DYAI
DYADIC INTERNATIONAL INC
NASDAQ · Healthcare · Biotechnology · US
$0.38
−7.35%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 13.45x
- P/E 2028E
- —
- P/S forward
- 1.72x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -6.39x
- Price / sales
- 4.39x
- Price / cash flow
- -2.06x
Enterprise value
- Enterprise value
- $17.2M
- EV / sales
- 4.95x
- EV / EBITDA
- -2.39x
- EV / EBIT
- -2.32x
- Market cap
- $15.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026